drugset / Trial / NCT00074776

Acute Treatment of Bipolar II Depression

NCT00074776 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

This study will compare the medications lithium and lamotrigine (Lamictal®) in treating depression in individuals with bipolar II disorder.

Timeline

Start
2003-05
Primary completion
2007-10
Completion
2007-10

Outcome

Missed primary endpoint

paper Both groups showed significant improvement from baseline to endpoint on the Ham-D(17) (p<0.0001), with no between group differences (p=0.95). PMID 18358540 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamotrigine Small molecule 200 mg —
Subject Lithium Unknown 900 mg —

Indications